Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Blinatumomab | Blincyto | View | ||
| Amoxicillin | Augmentin | View | ||
| Doxycycline | Doxycycline | View | ||
| Diclofenac Sodium | Voltaren | View | ||
| Etanercept | Enbrel | View | ||
| Direct Acting Antivirals (DAAs) | Direct Acting Antivirals (DAAs) | View | ||
| Galantamine Hydromromide | Reminyl | View | ||
| Tiapride | Tiapridal | View | ||
| Riociguat | Adempas | View | ||
| Amlodipine Besylate Valsartan | Amlor plus | View |